Literature DB >> 27913875

Another atypical case of acute kidney injury-or not? Answers.

Werner Keenswijk1, Johan Vande Walle2.   

Abstract

Entities:  

Keywords:  Acute kidney injury; Child; Chronic kidney disease; Enteric hyperoxaluria; Intestinal subobstruction; Malabsorption; Vomiting

Mesh：

Substances：

Year:  2016        PMID： 27913875     DOI： 10.1007/s00467-016-3551-x

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  8 in total

1.  Renal pyramids: focused sonography of normal and pathologic processes.

Authors:  Alan Daneman; Oscar M Navarro; Gino R Somers; Arun Mohanta; José R Jarrín; Jeffrey Traubici
Journal:  Radiographics       Date:  2010-09       Impact factor: 5.333

Review 2.  Treatment of enteric hyperoxaluria.

Authors:  J Harper; M A Mansell
Journal:  Postgrad Med J       Date:  1991-03       Impact factor: 2.401

Review 3.  Primary and secondary hyperoxaluria: Understanding the enigma.

Authors:  Bhavna Bhasin; Hatice Melda Ürekli; Mohamed G Atta
Journal:  World J Nephrol       Date:  2015-05-06

4.  Effect of magnesium on calcium oxalate urolithiasis.

Authors:  C J Su; P N Shevock; S R Khan; R L Hackett
Journal:  J Urol       Date:  1991-05       Impact factor: 7.450

5.  Dietary oxalate and calcium oxalate nephrolithiasis.

Authors:  Saeed R Khan; Patricia A Glenton; Karen J Byer
Journal:  J Urol       Date:  2007-09-17       Impact factor: 7.450

6.  Parathyroid hormone as a marker for the differential diagnosis of acute and chronic renal failure.

Authors:  S Ozmen; R Danis; D Akin; T Cil; O Yazanel
Journal:  Ren Fail       Date:  2007       Impact factor: 2.606

7.  Secondary hyperparathyroidism: pathophysiology and treatment.

Authors:  Wissam Saliba; Boutros El-Haddad
Journal:  J Am Board Fam Med       Date:  2009 Sep-Oct       Impact factor: 2.657

Review 8.  The management of patients with enteric hyperoxaluria.

Authors:  John R Asplin
Journal:  Urolithiasis       Date:  2015-12-08       Impact factor: 3.436
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.